{
    "clinical_study": {
        "@rank": "129568", 
        "brief_summary": {
            "textblock": "Purpose of study: to check the effect of medical cannabis given for approved medical\n      indications on ocular parameters including intra ocular pressure, optic nerve fibers\n      thickness and choroidal thickness."
        }, 
        "brief_title": "Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intra Ocular Pressure", 
        "condition_browse": {
            "mesh_term": "Marijuana Smoking"
        }, 
        "detailed_description": {
            "textblock": "Purpose of study: to check the effect of medical cannabis given for approved medical\n      indications on ocular parameters including intra ocular pressure, Retinal Nerve Fiber Layer\n      (RNFL) thickness, optic nerve fibers thickness and choroidal thickness.\n\n      Adult patients with no ocular pathology that are being treated in the neurology or pain\n      clinics with medical cannabis for different indications, were examined in the eye clinic.\n\n      First examination took place after the patient was not smoking for 5 hours. Three more\n      examinations took place 1 hour 3 hours and 5 hours after smoking cannabis.\n\n      The following parameters were checked: blood pressure, pulse, visual acuity, intra ocular\n      pressure, corneal thickness, axial length, slit lamp examination of anterior segment,\n      fundoscopy and Optical Coherence Tomography (OCT) of the retina, and optic nerve."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age over 18\n\n          -  Treated with medical cannabis for approved medical indications\n\n        Exclusion Criteria:\n\n          -  Known ocular pathology\n\n          -  Topical or systemic treatment for intra ocular pressure\n\n          -  Previous topical, intra ocular or systemic steroid treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Adult patients over the age of 18,  with no ocular pathology that are being treated in the\n        neurology or pain clinics with medical cannabis for different indications."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02080676", 
            "org_study_id": "CMC-14-0001-CTIL"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cannabis", 
            "Intra ocular pressure", 
            "Ocular perfusion", 
            "Blood pressure"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "contact": {
                "email": "Nurit.Mathalone@clalit.org.il", 
                "last_name": "Nurit Mathalone, MD", 
                "phone": "97248250477"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Carmel Medical Center"
            }, 
            "investigator": {
                "last_name": "Orna Geyer, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow", 
        "overall_contact": {
            "email": "orna_geyer@clalit.org.il", 
            "last_name": "Orna Geyer, MD", 
            "phone": "97248250926"
        }, 
        "overall_official": {
            "affiliation": "Carmel Medical Center", 
            "last_name": "Orna Geyer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Intra ocular pressure", 
            "safety_issue": "No", 
            "time_frame": "5 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02080676"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Carmel Medical Center", 
            "investigator_full_name": "Orna Geyer", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Carmel Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Carmel Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}